Nitric oxide

Key facts

Invented name
INOmax
Active substance
Nitric oxide
Therapeutic area
Cardiovascular diseases
Decision number
P/256/09
PIP number
Nitric oxide
Pharmaceutical form(s)
Inhalation gas
Condition(s) / indication(s)
  • Other pulmonary heart disease
  • Persistent Pulmonary Hypertension
Route(s) of administration
Endotracheopulmonary use
Contact for public enquiries
Applicant: INO Therapeutics AB
E-mail: Cecilia.dahlgren@linde-gas.com
Country: Sweden
Phone: +46 702500055
Fax: +46 87655287
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating